Plenty Of Opportunity In AbbVie, Even After Recent Run By: Benzinga via Benzinga October 02, 2017 at 12:18 PM EDT Analysts at Leerink Swann turned bullish on AbbVie Inc (NYSE: ABBV) and sees continued upside to the stock on top of the 43 percent gain ... Read More >> Related Stocks: AbbVie Amgen